Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus placebo added to ketamine-based rapid sequence intubation
ACTRN12616001570471Phase 3Completed
- Sponsor
- Ian Ferguson
- Start
- Aug 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rapid sequence induction (RSI) comparing Fentanyl + ketamine + rocuronium with Placebo + ketamine + rocuronium (2 arms). Primary endpoint: Patients with systolic blood pressure outside 100-150 mmHg. Started Aug 2018; status: completed.
02
Drugs
fentanylketaminerocuronium
03
Conditions
rapid sequence induction (RSI)
Beyond the preview
Go deeper on ACTRN12616001570471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001570471.